Development of pulmonary tuberculosis following treatment with anti-PD-1 for non-small cell lung cancer

To the Editor,Pharmaceutical blockade of immune checkpoint inhibitors has become a cornerstone in the treatment of several malignancies. Many patients experience immune-related adverse events [1]. ...